Zinc and copper (DrugBank: Zinc, Copper)
4 diseases| 告示番号 | 疾患名(ページ内リンク) | 臨床試験数 | 
|---|---|---|
| 2 | 筋萎縮性側索硬化症 | 1 | 
| 169 | メンケス病 | 0 | 
| 170 | オクシピタル・ホーン症候群 | 0 | 
| 171 | ウィルソン病 | 0 | 
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01259050 (ClinicalTrials.gov) | October 2010 | 10/12/2010 | Safety Study of High Doses of Zinc in ALS Patients | Phase 1 Open Label Study of Zinc Therapy in ALS Patients | Amyotrophic Lateral Sclerosis | Drug: Zinc and Copper | Phoenix Neurological Associates, LTD | NULL | Completed | 18 Years | 85 Years | Both | 10 | Phase 1;Phase 2 | United States |